GlaxoSmithKline launches Relenza stockpiling programme
This article was originally published in Scrip
US employers can purchase doses of GlaxoSmithKline's antiviral Relenza (zanamivir) or reserve specified quantities for eventual purchase in the event of an influenza pandemic under a new stockpiling programme.
You may also be interested in...
Generic drugs program has approved almost 300 manufacturing changes to help shore up the supply chain, with some prior approval supplements being downgraded to ‘changes being effected’ supplements, FDA officials said at GDUFA III kick-off meeting.
Coronavirus Notebook: Fauci Calls For Restraint In Disclosing Early Data; Bipartisan Lawmakers Want Warp Speed Audit
Dispatches from a world turned upside down also include the conditional approval of remdesivir in South Korea.
US FDA’s ‘may be effective’ standard for granting an emergency use authorization is expected to be comparable to the substantial evidence of effectiveness needed to support full licensure of a COVID-19 vaccine, although EUA allows for a more rapid review, agency officials say.